by Aucentra Admin | Aug 23, 2023 | Aucentra News
Aucentra is very excited to welcome Dr Tina Lavranos to the Aucentra team!! Dr Lavranos has been appointed as Chief Business and Commercialisation Officer. Tina’s extensive experience in biotech and life sciences, her expertise in drug discovery and development of...
by Aucentra Admin | Nov 11, 2022 | Aucentra News
Aucentra Therapeutics is pleased to announce the appointment of Dr David Fuller as ‘Chief Medical Officer’ and a member of the executive management team commencing 16 November 2022. Dr Fuller will lead the company’s Australia and global clinical development at a...
by Aucentra Admin | Nov 10, 2022 | Aucentra News
Aucentra is very excited to announce our most recent addition to the growing team – Ms Maria Maieli, Chief Financial Officer. Maria is an accomplished executive with extensive experience in commercially driven industries having worked 30 years in a combination of...
by Aucentra Admin | Jun 28, 2022 | Aucentra News
ADELAIDE, Australia- 12 May 22 On 12th May 2022, Professor Shudong Wang, invited by the University of South Australia Dean of Research Clinical Health & Sciences, held a live webinar to discuss her ground-breaking pancreatic cancer research drug discovery and...
by Aucentra Admin | Mar 28, 2022 | Aucentra News
ADELAIDE, Australia – 25/03/2022 Aucentra Therapeutics (https://www.aucentra.com/) is pleased to announce the appointment of Mr. Joe Bayer as Chief Executive Officer to lead the company in its growth and commercial phase. Aucentra Therapeutics is a clinical stage...
by Aucentra Admin | Feb 25, 2022 | Aucentra News
24 February 2022 Adelaide, Australia- Aucentra Therapeutics is pleased to announce that it has received regulatory approval to progress to a Phase 1a/b clinical trial of Auceliciclib (AU3-14) in combination with Temozolomide for recurrent/refractory GBM patients....
Recent Comments